The incidence of anaphylaxis following vaccination with Pfizer–BioNTech’s COVID-19 vaccine is slightly higher than that of schedule vaccines, so health professionals must be able to recognise this potentially fatal condition and differentiate it from immunisation stress-related responses, explain Marleen Hart, Aimee Brass and Shelley Kininmonth